RA Capital Nexus Fund III, L.P., Director at Mineralys Therapeutics, Inc. (MLYS), bought 2,985,629 shares at $16.00 ($20.0M) on 2023-02-14, disclosed to the SEC on 2023-02-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,735,629 | $0 | 0.0% |
| 2 | $16.00 | 131,600 | $2.1M | 10.5% |
| 3 | $16.00 | 1,118,400 | $17.9M | 89.5% |
| Total | $6.70 avg | 2,985,629 | $20.0M | 100% |
| Filing → |
| BCAX | BUY | 2024-09-18 | $33.0M | — | Filing → |